Yongyang Yun
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
ODF3B Promotes the Progression of Clear Cell Renal Cell Carcinoma via the JAK/STAT Signaling Pathway.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: March 25, 2026
Correction: SPAG6 hypermethylation silences a novel tumor suppressor and inhibits renal cell carcinoma progression via PI3K/AKT/mTOR pathway.
Journal: PloS one
Published: March 13, 2026
APOC2 Promotes Clear Cell Renal Cell Carcinoma Progression via Activation of the JAK-STAT Signaling Pathway.
Journal: Current issues in molecular biology
Published: October 14, 2025
PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma.
Journal: Cancer cell international
Published: August 01, 2025
RETRACTED: SPAG6 hypermethylation silences a novel tumor suppressor and inhibits renal cell carcinoma progression via PI3K/AKT/mTOR pathway.
Journal: PloS one
Published: July 17, 2025
COL1A1 promotes clear cell renal cell carcinoma progression through the Wnt/β-catenin signaling pathway.
Journal: Cellular signalling
Published: June 15, 2025
Renal tuberculosis in a patient with horseshoe kidney: a case report.
Journal: BMC infectious diseases
Published: October 08, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026